Pharmacy Stroke Comparison

Compare door to needle time for administration of tPA when a pharmacist is present versus when a pharmacist is not present. Secondary objectives include evaluation of reasons for tPA exclusion, assessment of blood pressure control, evaluation of adverse outcomes after administration of tPA, evaluation of appropriate initiation of aspirin, VTE prophylaxis and statin therapy after stroke, assessment of functional outcomes and disposition after tPA administration and identification of areas of improvement in the stroke management process.

August 09, 2017

  • Clinical Trial Information

    Trial Contact: Sawyer, Sandra

    Trial Phone: 321.841.3683

  • Age Group: Adult

    Phase: Not applicable

    Principal Investigator: Michael S. Mokris, MD

    Sub Investigators: N/A

    IRB No: 15.127.10

    Secondary Protocol No:

    Applicable Disease Sites: None